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Abstract
liver-enriched gene 1 (leg1) is a liver-enriched gene in zebrafish and encodes a novel protein. Our preliminary data suggested
that Leg1 is probably involved in early liver development. However, no detailed characterization of Leg1 has been reported
thus far. We undertook both bioinformatic and experimental approaches to study leg1 gene structure and its role in early
liver development. We found that Leg1 identifies a new conserved protein superfamily featured by the presence of domain
of unknown function 781 (DUF781). There are two copies of leg1 in zebrafish, namely leg1a and leg1b. Both leg1a and leg1b
are expressed in the larvae and adult liver with leg1a being the predominant form. Knockdown of Leg1a or Leg1b by their
respective morpholinos specifically targeting their 59-UTR each resulted in a small liver phenotype, demonstrating that both
Leg1a and Leg1b are important for early liver development. Meanwhile, we found that injection of leg1-ATG
MO,a
morpholino which can simultaneously block the translation of Leg1a and Leg1b, caused not only a small liver phenotype
but hypoplastic exocrine pancreas and intestinal tube as well. Further examination of leg1-ATG
MO morphants with early
endoderm markers and early hepatic markers revealed that although depletion of total Leg1 does not alter the hepatic and
pancreatic fate of the endoderm cells, it leads to cell cycle arrest that results in growth retardation of liver, exocrine pancreas
and intestine. Finally, we proved that Leg1 is a secretory protein. This intrigued us to propose that Leg1 might act as a novel
secreted regulator that is essential for liver and other digestive organ development in zebrafish.
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Introduction
Liver expresses vast varieties of genes, including liver-specific
and/or –enriched genes, to encode different proteins necessary for
executing its diverse functions [1–3]. For example, liver produces
and secretes a variety of serum proteins, such as albumin,
fibrinogen, prothrombin and antithrombin etc, to maintain
homeostasis of the body [4]. In many cases, the expression of
liver-specific and/or –enriched genes are under the control of a
network formed by transcription factors including hepatic nuclear
factors HNF1, HNF3, HNF4, HNF6, and C/EBPa (CCAAT/
enhancer binding protein) etc [3–6]. Extensive genetic studies have
demonstrated that, in addition to their roles in controlling the
expression of metabolic genes, all HNF proteins are also essential
for liver organogenesis.
The process of liver organogenesis is governed by a network
formed by HNF factors, GATA factors, and morphogens
including FGF, BMP and Wnt2 [7–9]. This genetic network
coordinates expression and functions of many genes to guide the
liver to develop into the right size and shape at the right time and
place. Much has been learned about the physiological and
biochemical functions of genes expressed in the adult liver
[3,10–12]. However, due to restriction of experimental systems,
few studies have been carried to identify genes with their
expression enriched in both a developing liver and a mature liver
and thereof their functions in both processes. This work is
particularly important since continuous expression of this set of
live-enriched genes from the fetal to adult stages suggest their
essential roles in both early liver development and stem cell
function and/or the status maintainence in an adult liver [13]. The
latter function is crucial for liver regeneration after hepatectomy.
Zebrafish (Denrio rerio) has been proven to be an excellent genetic
model system to study both processes of liver development and
liver regeneration [9,14,15]. Liver organogenesis in zebrafish
shares similar mechanism with mammals and other vertebrates
with regard to the processes of morphogenesis and molecular
control [16–20]. In addition, a number of novel positive/negative
factors essential for liver organogenesis in zebrafish, including
Vps18, Sox9a and Fgr (Foie gras), Npo (Nil per os), Def etc [21–
24], have been identified via studying genetic mutants.
We previously reported the identification of 129 adult liver-
enriched genes in zebrafish through the microarray approach [3].
Further whole-mount in situ hybridization (WISH) studies revealed
that 69 out of these 129 genes were also enriched in the embryonic
liver [3]. Our main interest is in understanding if such adult liver-
enriched genes also function in early liver development. A novel
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e22910gene, leg1 (live-enriched gene 1) was among these 69 liver-enriched
genes. Our preliminary functional study via morpholino-mediated
gene knock-down approach showed that that leg1 morphant
conferred a small liver phenotype [3]. In this work, we reported
our more detailed studies on the leg1 gene. We found that there are
two copies of leg1, namely leg1a and leg1b, in zebrafish, and Leg1
proteins are highly conserved among vertebrates. We confirmed
that both Leg1a and Leg1b play important roles during liver
development. More importantly, we demonstrated that Leg1 is a
secretory protein. These results suggest that Leg1 might function
as a novel secreted regulator for the liver development.
Methods
Ethics Statement
This study does not involve non-human primates. Research
work has been performed in full accordance to the requirement by
‘Governing Regulation for the Use of Experimental Animals in
Zhejiang Province’ (Zhejiang Provincial Government Order
No 263, released in August 27, 2009, effective from October 1,
2010). According to the Chapter for Biosafety and Animal Ethics
(Chapter 4), as stated in Line 28: ‘Units and individuals who are
conducting the production and use of experimental animal
production, should treat animals humanely and protect animal
welfare, should not tease and abuse animals. The use of
experimental animals should be in accordance to the scientific,
rational and humane requirements. It is advised and encouraged
to minimize the use of laboratory animals to reduce suffering of
animals to be disposed of, and to explore of alternative methods in
replacing animal testing and use’, ethical approval is not stated to
be required for scientific research using adult or embryonic
zebrafish by the Regulation. Every effort was made to minimize
any suffering of the animals used in this study. Zebrafish (Danio
rerio) wild type AB strain was used in this study. Adult zebrafish was
euthanized in Tricane solution before being dissected for tissue
collection. Zebrafish was raised up and maintained in the standard
Zebrafish Unit (produced by Aisheng Zebrafish Facility Manu-
facturer Company, Beijing, China).
Whole-mount in situ hybridization (WISH)
RNA probes were obtained from fabp10a and leg1a plasmids
respectively by in vitro transcription (T3 RNA polymerase kit,
Promega), and were labeled with digoxigenin-UTP (DIG-labeling)
(Roche Diagnostics). WISH was performed as described previously
[3].
Zebrafish Leg1 monoclonal antibody preparation
leg1a cDNA full length sequence was amplified using primers
leg1a-fd and leg1a-re (leg1a-fd, forward: 59-TGTCTGGAT-
TCGGTTTCCTGCGATCAGTG-39; leg1a-re, reverse: 59-TAC-
CACGAATTCAGCAGCTGGTGGACATCT-39) and cloned
into pGEX-6P-1 (Clontech) between BamHI and EcoRI cloning
sites. Leg1 protein was expressed in E. coli, purified and used as the
antigen. Monoclonal antibody against zebrafish Leg1 was
prepared by the Monoclonal Antibody Unit in the Institute of
Molecular and Cell Biology, Singapore.
RNA and protein analysis
Total RNA was extracted from embryos at different develop-
mental stages using TRIzol (Invitrogen, USA). Probes were DIG-
labeled and Northern blotting was performed accordingly to
manufacturer’s instruction (Roche Diagnostics) [3]. For analyzing
leg1a and leg1b expression ratio, first strand cDNA was synthesized
using Superscript II (Invitrogen, USA) followed by PCR with
forward primer (Fwd 59-GCCCCGGGGAGCAGGAGAATC-39)
and reverse primer (Rev 59-GCTGGACCCGGGGAACTTTG-
39).PCRproductswereclonedintopGEM-Teasyvector(Promega).
65clonesfrom each developmentalstage wererandomly pickedand
sequenced. Sequences obtained were analyzed to identify the ones
corresponding to leg1a or leg1b. For western blotting, total protein
was extracted using standard SDS sample buffer. Western blotting
was performed as described previously [25] using monoclonal
antibody against zebrafish Leg1 as the primary antibody. Total 12
adult zebrafish (five months old) were used extracting total RNA
and protein, respectively.
Morpholinos
Morpholinos were obtained from GeneTools (Philomath, USA).
leg1-MO
ATG morpholino (59-CCATCTCAGACATCTAGCAG-
GACTG-39) was designed to target the translation start site regions
of both leg1a and leg1b. Its 5-base mismatch morpholino (59-
CCATgTCAcACATgTAGCAcGAgTG-39)wasdesignedandused
as the mismatch control (st-MO). leg1a-MO (59-AGTCCAGCA-
GAGAGGAGCTTTAATC-39) and leg1b-MO (59-CCGGGCCA-
CATACTGAATGGAATGA-39) morpholinos were designed to
target the 59-UTRs of leg1a and leg1b, respectively. 1 nl of leg1-
MO
ATG (0.5 nmol/ml), st-MO control (0.5 nmol/ml), leg1a-MO
(0.2 nmol/ml), or leg1b-MO
UTR (0.7 nmol/ml) was injected into
one-cell stage embryos.
mRNA rescue
leg1a and leg1b cDNAs were obtained via RT-PCR using primer
pairs shared by leg1a and leg1b (leg1-fd1, forward: 59-TCAG-
GAATTCGATGGGTTTCCTGCGATCAG-39, leg1-re1, reverse:
59-TCAGTTCTAGATCAGCAGCTGGTGGACAT-39)a n dw e r e
cloned to pCS2+ vector by EcoRI and XbaI cloning sites. The identity
of leg1a or leg1b was determined based on SNPs (single nucleotide
polymorphism) between these two homologs after sequencing
individual clones. leg1a and leg1b mRNAs were obtained from their
respective plasmids via in vitro transcription using the Message
Machine Kit (Ambion). For morphant phenotype rescue, 0.3 ng of in
vitro transcribed WT leg1a or leg1b mRNA was injected into one-cell
stage embryos.
59 and 39 RACE
The FirstChoiceH RLM-RACE kit (Ambion) was used to
determine the transcription start sites of leg1 and leg1b, and to
obtain the 59-UTR and 39-UTR sequences corresponding to leg1a
and leg1b, respectively. Experiments were carried out according to
the manufacturer’s instruction with total RNA as the starting
material for first-strand cDNA synthesis.
Phosphorylated Histone 3 (PH3) immuostaining and
TUNEL assay
Embryos were collected at 38 hpf and 3 dpf, respectively.
Embryos were fixed and embedded and sectioned as described
[22]. Cell cycle progression was analyzed by immunostaining PH3
and cell apoptosis by TUNEL as described [22].
Liver size measurement
The liver of an embryo at 90 hpf was marked out by WISH
using the fabp10a probe. We assumed that the thicker part of the
liver would be stained darker hence blocking more light
penetration. This in turn will yield stronger signal intensity upon
negative image capturing. Therefore, we could use signal
intensities to infer the liver size. Firstly, an image of the liver
was captured from the left lateral view after aligning two eyes of
Secretory Protein Leg1 and Liver Development
PLoS ONE | www.plosone.org 2 August 2011 | Volume 6 | Issue 8 | e22910Figure 1. Leg1a and Leg1b are two closely related homologs in zebrafish. (A) Diagram showing the arrangement of leg1a and leg1b on
chromosome 20. (B) RT-PCR showing the expression of leg1a and leg1b in adult liver. Primer pairs amplifying leg1a are derived from exon1 of leg1a
(lanes 1 and 2), leg1b are from exon1 and exon2 of leg1b (lanes 3 and 4). Lanes 1 and 3: cDNA as template; lanes 2 and 4: genomics DNA as template.
(C) Diagram showing leg1a and leg1b genomic structures. Red box: exon; uneven line: introns. (D) Alignment of Leg1a and Leg1b amino acid
sequences to highlight the 39 different amino acids between them (boxed in red).
doi:10.1371/journal.pone.0022910.g001
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among each individual embryo. Next, the image of individual
embryo was used to obtain fabp10a staining signal intensity by
Nikon image system (NIS-elements D v3.0).
Phylogenetic analysis
Leg1 homologs from different species were selected from the
cluster of proteins containing the DUF781 domain identified using
PANTHER (Protein Analysis Through Evolutionary Relation-
ships, http://www.pantherdb.org/). Protein sequences were then
retrieved and aligned via Clustal W program. Phylogenetic tree
was built with MEGA 4 program [26].
Signal peptide prediction
HMM (Hidden Markov models) method in SignalP (http://
www.cbs.dtu.dk/services/SignalP/) was used to predict signal
peptide in Leg1. The probabilities that the Leg1 leading sequence
is a signal peptide and signal anchor are 0.995 and 0.004,
respectively. And the probability to be a signal peptidase cleavage
site, locating between position 22 and 23, is 0.924 [27].
Results
leg1a and leg1b are two closely linked homologous
genes in zebrafish
We previously reported a brief data showing that knockdown of
Leg1 expression by a morpholino (leg1-MO
ATG) targeting the start
codon ATG of leg1 caused smaller liver in zebrafish [3]. Notably,
there is no other report on Leg1 in any systems thus far. We
initiated the work with the purpose to characterize zebrafish leg1
gene in more detail. We first blasted the obtained leg1 cDNA
sequence [3] against the zebrafish genome sequence assembled in
Zv6 (http://www.sanger.ac.uk/Projects/D_rerio). We found that
there is a leg1 homolog positioned in adjacent to the initial leg1
gene on chromosome 20 separated by 6.03 kb (counting from the
last base of 39-UTR of leg1b to the transcription start site of leg1a)
(Fig. 1A). To find out whether the newly discovered homolog gene
is transcribed, we designed primers for the new homolog based on
its genomic sequence for RT-PCR. The RT-PCR products
(Fig. 1B) were sequenced and the sequence was found to match
the predicted transcript for the new homolog (Fig. S1). Thereafter,
these two homologs are designated as leg1a and leg1b, correspond-
ing to the initial leg1 and new homolog, respectively. Alignment of
leg1a and leg1b transcribed sequences with their respective genomic
DNA sequence reveals that leg1a has 6 exons and 5 introns
whereas leg1b has 7 exons and 6 introns (Fig. 1C). Despite the
differences in their genomic structures, both of the coding
sequences of leg1a and leg1b are 1083 nucleotides in length sharing
high homology (95.2%) (Fig. S1). Amino acids alignment shows
that Leg1a and Leg1b share 90.6% identity and differ only in 39
amino acids (Fig. 1D).
Phylogenetic analysis of Leg1
Extensive database search reveals that Leg1a and Leg1b
represent a new family of proteins present in other animal species
characterized by a conserved domain DUF781 (domain of
Figure 2. Phylogenetic analysis of Leg1. (A) Leg1 family is featured by the domain of unknown function 781 (DUF781) (blue bar). Yellow bar: N-
terminal leading peptide. (B) Phylogenetic analysis of Leg1. Human: NP_001010905.1; Pan troglodytes: XP_518733.2; Macaca mulatta:
NP_001181247.1; Canis familiaris a: XP_855514.1; Canis familiaris b: XP_864054.1; Bos taurus a: ENSBTAG00000017166; Bos taurus b:
ENSBTAG00000026578; mouse: NP_080612.1; Rattus norvegicus: XP_001059712.1; Monodelphis domestica: XP_001380262.1; Ornithorhynchus anatinus
a: ENSOANG00000002104; Ornithorhynchus anatinus b: ENSOANG00000008387; Gallus gallus a: XP_419749; Gallus gallus b: XP_001232481; Danio rerio
a: NP_001093526.1; Danio rerio b: NP_998368.1; Fugu rubripes: ENSTRUT00000034344; medaka: ENSORLT00000022610.
doi:10.1371/journal.pone.0022910.g002
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Leg1 is well-conserved among vertebrates. Zebrafish Leg1a and
Leg1b are closely related to Leg1 homologs in teleost including
fugu rubripes (49% identity) and medaka fish (50% identity) but
display a significant evolutional distance from mammals including
rat (36% identity), mouse (36% identity), dog (34% identity),
Rhesus monkey (36% identity) and human (36% identity) (Fig. 2B).
leg1a and leg1b are differentially expressed
The facts that leg1a and leg1b share high sequence homology in
the coding region and are neighboring to each other on
chromosome 20 prompt us to investigate whether leg1a and leg1b
are equally expressed in zebrafish at different developmental
stages. We first performed 59- and 39-RACE to identify the 59- and
39-untranslated regions (UTR) for leg1a and leg1b, respectively.
Sequence alignment revealed that, in addition to the high
homology shared in the coding region, the 39-UTRs of leg1a and
leg1b are also highly homologous except that leg1b has additional
16 nucleotides just after the stop codon TGA (Fig. 3A). On the
other hand, the 59-UTRs of leg1a and leg1b are totally divergent
except that they share 20 identical nucleotides just ahead of the
start codon ATG (Fig. 3A).
The high homology between leg1a and leg1b makes it difficult to
distinguish their expression patterns based on WISH or northern
blotting using probes derived from their coding regions. To
address this problem, we performed RT-PCR using a pair of
primers perfectly matching both leg1a and leg1b sequences and
cloned RT-PCR products into the T-vector. Bacteria colonies
were randomly picked and sequenced to identify clones corre-
sponding to leg1a or leg1b based on SNPs (single nucleotide
polymorphism) between leg1a and leg1b. The result showed that,
for embryos examined at 1dpf, 2 dpf, 3 dpf, and 4 dpf, the
percentage of clones representing leg1a was approximately 97%,
90%, 96%, 98% and was accordingly higher than that for leg1b
Figure 3. leg1a and leg1b are differentially expressed. (A) Alignment of 59- and 39-UTRs of leg1a and leg1b transcripts, respectively. Asterisk
highlights identical bases. Translation start codon ATG and stop codon TGA are lettered in red. (B) Comparison of leg1a and leg1b expression at
different developmental stages as indicated. Data are presented in percentage (blue bar: leg1a; red bar: leg1b). (C) Anti-Leg1 monoclonal antibody
recognizes both Leg1a and Leg1b which were induced to express in E. coli by isopropyl b-D-1-thiogalactopyranoside (IPTG). (D) Western blotting
analysis of total Leg1 (Leg1a+Leg1b) expression in embryos at stages as indicated.
doi:10.1371/journal.pone.0022910.g003
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leg1a transcripts are more abundant than leg1b transcripts during
embryogenesis. We also checked leg1a and leg1b expression in the
adult liver and found that leg1a was also more dominantly
expressed (61%) than was leg1b (39%) (Fig. 3B).
The above data suggest that leg1a and leg1b expression are
differentially regulated. Gene expression is controlled and
regulated by its promoter. We retrieved 3 kb of genomic DNA
sequences upstream of leg1a and leg1b transcription start site,
respectively, and aligned them using Ebi Tool needle program
(Fig. S2). Comparison of leg1a and leg1b promoter sequences
identified two highly conserved regions. The first region spans
,510 bp (2636 to 21150 for leg1a, 22510 to 23016 for leg1b,
counting from the first base upstream of the transcription start site
for leg1a and leg1b, respectively) (Fig. S2, letters in red). The second
region spans ,310 bp (21151 to 21468 for leg1a, 23068 to
23380 for leg1b, respectively) (Fig. S2, letters in purple). However,
all of the rest sequences, especially the 600 bp proximal promoter
directly upstream of the transcription start sites, are highly
divergent between these two genes (Fig. S2). This might explain
the expression difference between leg1a and leg1b at different
developmental stages.
Both Leg1a and Leg1b are important for normal liver
development
A monoclonal antibody recognizing both Leg1a and Leg1b
(Fig. 3D) was used to analyze the temporal expression patterns of
total Leg1 (Leg1a+Leg1b). The results showed that total Leg1 can
be detected in the larvae from 12 hpf onwards with a gradual
increase in signal intensity until 6 dpf (Fig. 3E).
We reported previously that leg1-MO
ATG injection led to a
small liver phenotype [3]. Rechecking the morpholino sequence
we noticed that leg1-MO
ATG in fact, because of sequence
conservation between leg1a and leg1b, targeted both leg1a and leg1b
at their respective translation start site regions (leg1-MO
ATG).
Therefore, the morphant phenotype observed [3] was believed to
be due to knockdown of both Leg1a and Leg1b in the morphants.
To prove this speculation, we checked total Leg1 proteins in leg1-
MO
ATG morphants and found that total Leg1 protein expression
was almost depleted in the protein extracts from the leg1-MO
ATG
morphants at 3dpf (Fig. 4K).
To determine which homolog(s), Leg1a or Leg1b or both,
play(s) a role in liver development, we designed two morpholinos,
leg1a-MO and leg1b-MO, specifically targeting the 59-UTR of
leg1a and leg1b, respectively. To check the potency of these two
Figure 4. Knockdown of Leg1a or Leg1b protein expression with their specific morpholinos. (A) Diagram showing construction of leg1a-
59-UTR:rfp (59UTRa:RFP) and leg1b-59-UTR:gfp (59UTRb:GFP) plasmids. (B–I) 59UTRa:RFP and 59UTRb:GFP were mixed and co-injected with st-MO (B, F),
leg1-MO
ATG (C, G) or leg1a-MO (D, H), or leg1b-MO (E, I). Rfp (B–E) and Gfp (F–I) fluorescence was visualized under a Nikon fluorescence microscope.
(J) Western blotting analysis of Rfp and Gfp proteins in the injected embryos as indicated using antibodies against Rfp and Gfp, respectively. (K)
Western blotting analysis of total Leg1 in different morphants as indicated.
doi:10.1371/journal.pone.0022910.g004
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to the upstream of the reporter gene rfp (red fluorescence protein)( leg1a-
59-UTR:rfp) and gfp (green fluorescence protein)( leg1b-59-UTR:gfp),
respectively (Fig. 4A). The leg1a-59-UTR:rfp and leg1b-59-UTR:gfp
plasmid DNA were mixed and co-injected with leg1-MO
ATG,o r
leg1a-MO, or leg1b-MO into embryos at one-cell stage. At 10 hpf,
Rfp or Gfp fluorescence was observed under a fluorescence
microscope. Meanwhile, total proteins were extracted and
subjected to western analysis. As expected, we found that leg1-
MO
ATG blocked both Rfp and Gfp expression (Fig. 4B, C, F, G, J).
On the other hand, leg1a-MO but not leg1b-MO diminished the
expression of Rfp fluorescence (Fig. 4D, H, J) and vice versa, leg1b-
MO but not leg1a-MO abrogated the expression of Gfp
fluorescence in the injected embryos (Fig. 4E, I, J). These data
demonstrate that these two morpholinos worked with high
specificity and efficiency.
Next, we compared the efficiencies of leg1a-MO and leg1b-MO
on the knockdown of total endogenous Leg1 protein expression.
While leg1-MO
ATG depleted almost all total Leg1 protein
expression leg1a-MO was found to deplete more than 75% of
total Leg1. On the other hand, leg1b-MO depleted approximately
half of total Leg1 protein (Fig. 4K). Examination of liver
development in leg1a-MO and leg1b-MO morphants using the
liver specific marker fabp10a probe revealed that both morpholinos
Figure 5. Both Leg1a and Leg1b are essential for normal liver development. (A) leg1-MO
ATG (ATG-MO), leg1a-MO (1a-MO) and leg1b-MO
(1b-MO) all resulted in small liver phenotype but with different severity. (B) Statistical analysis of liver size in leg1-MO
ATG (ATG-MO), leg1a-MO (1a-MO)
or leg1b-MO (1b-MO) morphants based on WISH signal intensity of fabp10a. Signal intensity (Y-axis) was plotted against body length (X-axis). 20–23
embryos were used for statistical analysis in each case. (C) WISH using fabp10a probe to examine rescue of the small liver phenotype caused by leg1-
MO
ATG with leg1a (1a mRNA), leg1b (1b mRNA) mRNA, or combination of leg1a and leg1b mRNA (1a+1b mRNA). (D) Statistical analysis of liver size in
each individual leg1-MO
ATG morphant based on WISH signal intensity of fabp10a. 19–23 embryos were used for statistical analysis in each case except
for WT (14 embryos were used).
doi:10.1371/journal.pone.0022910.g005
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more severe small liver phenotype than did leg1b-MO (Fig. 5A, B).
In fact, leg1a-MO is near as potent as leg1-MO
ATG regarding
their effects on liver development (Fig. 5B). Together, these results
suggest that both Leg1a and Leg1b are necessary for normal liver
development.
Leg1a and Leg1b function partially redundant during
liver development
Since Leg1a and Leg1b share high homology with each other, it
is reasonable to speculate that the functions of these two proteins
are probably fully redundant and the degree of severity of small
liver exhibited by the leg1a-MO and leg1b-MO morphants would
only correlate to Leg1a and Leg1b expression levels in the liver.
This appeared to be the case since leg1a-MO morphants displayed
more severe phenotype than did leg1b-MO (Fig. 5A, B) when
considering leg1a is expressed higher than is leg1b in the liver
(Fig. 2B). We reasoned if Leg1a and Leg1b are fully functionally
redundant, overexpressing either leg1a or leg1b alone by mRNA
injection would then result in rescue of the small liver phenotype
conferred by the leg1-MO
ATG morphant similar to that by
injection of leg1a and leg1b mRNA combination. Using the marker
fabp10a to examine injected embryos at 4dpf (Fig. 5C), we found
that overexpressing Leg1a or Leg1b alone partially rescued the
liver size to a similar extent based on quantifying positive fabp10a
signal intensity at the liver site in leg1-MO
ATG morphants (Fig. 5C,
D). However, Leg1a achieved a higher rescue rate (16 out of 20
embryos examined) than did Leg1b (13 out of 23 embryos
examined) (Fig. 5D). Whereas co-injection of leg1a and leg1b
mRNA resulted in a more significant recovery of the liver size (15
out of 19 embryos examined) (Fig. 5C, D). These data suggest that
functions of Leg1a and Leg1b in liver development are partially
redundant.
Depletion of Leg1 blocks liver expansion but not liver
initiation
Digestive organs, including liver, pancreas and intestine, are all
originated from the endoderm. We asked if depletion of total Leg1
by leg1-MO
ATG morpholino would affect the organogenesis of
other digestive organs in addition to the liver. To address this
question, WISH was performed on leg1-MO
ATG morphants at 85
hpf using exocrine pancreatic marker trypsin, intestinal marker ifabp
(intestine fatty acid binding protein) and endocrine pancreas marker
insulin, respectively. The results showed that the exocrine pancreas
tail failed to extend and the intestinal tube was shortened and
thinned in the morphant embryos (Fig. 6A). On the other hand,
the endocrine pancreas marked by insulin was not obviously
affected (Fig. 6A). The data obtained suggest that Leg1 is also
essential for organogenesis of exocrine pancreas and intestinal
tube.
In zebrafish, the endoderm cells form a rod at around 24 hpf. At
around 30 hpf, the endoderm tube undergoes a process termed as
‘gut looping’ which pushes the liver bud to the left while turning
the pancreatic bud to the right of the body. At around 55 hpf, the
first phase of organogenesis of digestive organs is accomplished
[16,17,20,28]. To determine when the inhibitory effect of
depletion of Leg1 on liver and other digestive organ development
becomes discernable, we performed WISH using early endoderm
markers foxa3 and gata6 and early hepatic markers hhex and prox1
on embryos at 30 hpf and 55 hpf, respectively. We found that all
four markers are expressed in the leg1-MO
ATG morphant
embryos in a similar pattern as that observed in the wild type
(WT) control (Fig. 6B). Carefully examining the hybridization
signals of these markers we noticed that, however, expression of all
markers was reduced in signal intensity in the leg1-MO
ATG
morphant embryos (Fig. 6B). This data suggests that depletion of
Leg1 has no effect on the determination of the hepatic and
pancreatic fate of endoderm cells instead it blocks the expansion
growth of these organs.
Figure 6. Depletion of Leg1 affects the expansion but not
initiation of the liver, exocrine pancreas and intestinal tub. (A)
WISH using trypsin, ifabp and insulin as probes to examine the
development of exocrine pancreas (trypsin), intestine (ifabp) and
endocrine pancreas (insulin) in WT (W) and the leg1-MO
ATG morphant
(M) embryos at 85 hpf. (B) WISH using early hepatic markers hhex and
prox1 and early endoderm markers foxa3 and gata6 on WT and leg1-
MO
ATG morphant (ATG-MO) embryos at 30 hps and 55 hpf, respectively.
Blue arrow: liver; red arrow: pancreas; black arrow: intestine.
doi:10.1371/journal.pone.0022910.g006
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small liver phenotype in leg1-MO
ATG morphants
The small liver in leg1-MO
ATG morphants could be resulted
from restricted cell cycle progression or increased apoptosis or
both. To find out the cellular mechanism for the small liver
phenotype, we first performed immunostaining analysis using an
anti-phosphorylated Histone 3 (PH3) antibody on leg1-MO
ATG
morphant and WT control embryos, respectively. Results showed
that leg1-MO
ATG morphant at 38 hpf had significant less PH3-
positive cells (22 PH3-positive cells out of 846 total cells counted
Figure 7. Hypoplastic liver in leg1-MO
ATG morphants is caused by cell cycle arrest during the liver budding stage. (A, B)
Immunostaining using an anti-PH3 antibody on st-MO (A) and ATG-MO (B) morphants at 38hpf. Liver primordium is circled with a white dotted line.
(C, D) Immunostaining using antibodies respectively against PH3 (red) and RFP (green) on cross-sections from st-MO (C) and ATG-MO (D) morphants
in the Tg(lfabp: DsRed; elaA: EGFP) background at 3dpf. (E) Statistical analysis revealed that the ratio of PH3-positive cells was significantly reduced in
the liver primordium of ATG-MO morphants at 38 hpf, but no significant difference in the ratio of PH3-positive cells was observed in the liver of ATG-
MO morphants at 3dpf. Data was obtained by counting PH3-positive cells versus total cells in a specific organ (e.g. liver) in sections from at least 3 st-
MO embryos and 3 ATG-MO morphants at each stage, respectively (Table S1).
doi:10.1371/journal.pone.0022910.g007
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WT control (63 PH3-positive cells out of 923 cells counted from
sections from 4 embryos, account for 6.8%) (Fig. 7A,B,E; Table
S1). Counting of PH3-positive cells in the neural tube in the same
sections revealed no significant differences between leg1-MO
ATG
morphant (215 out of 9572 cells counted, accounting for 2.2%)
and WT (178 out of 8535 cells counted, accounting for 2.1%)
(Fig. 7A,B,E; Table S1). This data suggests that depletion of Leg1
results in cell cycle arrest specifically in the liver primordium but
not in the neural tube. Interestingly, at 3 dpf, while the morphant
liver is greatly reduced in size the ratio of PH3-positive cells (36
out of 897 cells counted from sections from 3 embryos, accounting
for 4%) was not much different from that in WT (81 out of 2734
cells counted from sections from 3 embryos, account for 3%)
(Fig. 7C–E). Next, we performed TUNEL assay to compare
apoptotic activities in the liver of leg1-MO
ATG morphant and WT
embryos at 3 dpf. As expected, no apoptotic cells (out of 2869 liver
cells counted) were identified in the WT liver. To our surprise, no
apoptotic cells (out of 679 liver cells counted) were identified in
sections from three leg1-MO
ATG embryos at the liver site either.
Therefore, the small liver phenotype in leg1-MO
ATG morphant is
caused due to cell cycle arrest rather than due to cell apoptosis.
Leg1a and Leg1b are novel secretory proteins
Analysis of Leg1a and Leg1b peptide sequences identified a
signal peptide at their N-termini (Fig. 8A), suggesting that Leg1a
and Leg1b are possibly secretory proteins. To determine whether
Leg1a is indeed a secretory protein, we cloned leg1a coding
sequence in-frame to the HA tag either before or after the tag
into expression vector pCS2+ (constructs leg1a-HA and HA-leg1a)
(Fig. 8B). leg1a-HA or HA-leg1a mRNA was respectively injected
into embryos at one-cell stage. The scenario is that if Leg1 is
secretory protein, the N-terminal tagged HA tag will be cleaved
together with the signal peptide and the matured Leg1 would fail
to be detected by anti-HA antibody. Conversely, if Leg1 is not a
secretory protein, the anti-HA antibody must recognize both
forms of Leg1 fusion proteins. Total proteins were extracted from
injected embryos at 8hpf and subjected to western blotting
analysis using monoclonal antibodies recognizing either HA tag
or Leg1 protein. Results showed that the anti-Leg1 antibody
detected Leg1a in both samples prepared from HA-leg1a and
leg1a-HA mRNA injected embryos, respectively (Fig. 8C). Fur-
thermore, Leg1 protein detected by anti-Leg1 antibody in the
leg1a-HA mRNA injected embryos is higher in molecular weight
than that that in the HA-leg1a mRNA injected embryos (Fig. 8C).
On the other hand, the anti-HA antibody could only detect the
HA-tagged protein in the leg1a-HA mRNA injected embryos
(Fig. 8C). The results obtained suggest that Leg1a is secretory
protein.
Next, we asked whether Leg1a and Leg1b are extracellular
protein. In the adult fish, total leg1 transcripts are detected mainly
in the liver and are almost undetectable in the head, tail, and trunk
(Fig. 8D). However, analysis of total Leg1 proteins via western
blotting using anti-Leg1 antibody showed that total Leg1 were
detected in these tissues in addition to the liver (Fig. 8E).
Furthermore, total Leg1 levels in head, tail and trunk were
comparable to that in the liver (Fig. 8E). Most strikingly, serum
contained the highest level of total Leg1 (approximately three
times higher) among all tissues tested (Fig. 8E). Therefore, Leg1 is
a novel secretory protein produced by the liver.
N-terminal signal peptide is essential for Leg1 function
Considering that Leg1 is a secretory protein, one intriguing
question to ask is whether the N-terminal signaling peptide is
Figure 8. Leg1a is a secretory protein. (A) The first N-terminal 25
amino acids of Leg1a were shown on the X-axis. Y-axis represents
probabilities. Green line: positively charged N-terminal end region; blue
line: hydrophobic core sequence containing 12 uncharged amino acids;
cyan line: recognition region by signal peptidase; red line: signal
peptide cleavage site. (B) Diagram showing construction of HA-leg1a
and leg1a-HA plasmids. (C) Western blotting detecting Leg1 proteins by
anti-Leg1 monoclonal antibody (left panel) and detecting Leg1-HA
fusion protein by anti-HA antibody (right panel). (D) Northern blotting
detecting total leg1 transcripts (leg1a+leg1b) in different tissues from
adult fish. 18S RNA staining was used as the loading control. (E) Western
blotting detecting total Leg1 (Leg1a+Leg1b) in different tissues from
adult fish. GAPDH and Coomassie blue staining (CB) were used as the
loading controls.
doi:10.1371/journal.pone.0022910.g008
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designed a construct which is deleted of the N-terminal signaling
peptide. This construct is used for generating mRNA in vitro and
such mRNA was co-injected with leg1-MO
ATG into embryos at
one-cell stage (Fig. 9A). Examination of embryos four days post-
injection with the fabp10a probe showed that the N-terminal
signaling peptide truncated Leg1 failed to rescue the small liver
phenotype caused by leg1-MO
ATG (Fig. 9B). This data suggests
that the N-terminal signal peptide is essential for Leg1 function.
Discussion
We chose leg1 in this work mainly for two reasons: firstly, Leg1 is
a novel protein whose function has never been reported in
previous studies except for our preliminary data showing that Leg1
might be involved in zebrafish liver development [3]. Secondly,
leg1 expression is enriched in both adult and embryonic liver, we
are intrigued to find out if Leg1 plays dual functions at these two
developmental stages in zebrafish liver. In this report, we focused
mainly on characterization of Leg1 protein and its role in early
liver development.
We found that zebrafish has two closely related leg1 homologs,
namely leg1a and leg1b. leg1a and leg1b share high homology in
their coding sequences, however, are divergent in their 59-UTR
sequences. Further studies showed that leg1a is predominantly
expressed than is leg1b in both embryos and adult liver,
demonstrating their expression is differentially regulated. Se-
quence alignment analysis showed that the 600 bp proximal
promoter sequences (promoter sequence directly upstream of the
transcription start site) share little homology between leg1a and
leg1b although they do have two conserved regions in their
distant promoter regions. This observation might explain why
leg1a is a prominent form during embryogenesis whilst both leg1a
and leg1b are highly expressed in the adult liver. Then, the
intriguing question to ask is whether, during evolution, nature
has assigned one homologue (i.e leg1a) to function in develop-
mental process and the other (ie. leg1b)t ob er e s p o n s i v et o
physiological or pathological stresses. Future effort is worth to be
made to find out how this differential expression is achieved in
vivo.
We previously showed that knockdown total Leg1 (Leg1a +
Leg1b) by leg1
ATG-MO conferred a small liver phenotype. In this
report, we proved that the small liver phenotype was caused duo to
cell cycle arrest rather than due to cell apoptosis. Apparently, our
future work will need to elucidate why depletion of Leg1
specifically impairs the cell cycle process but not cell apoptosis.
Upon discovery of leg1a and leg1b two homologs, we used highly
potent leg1a-specific (leg1a-MO) and leg1b-specific (leg1b-MO)
morpholinos to study their individual roles in liver development.
Our results showed that knockdown of Leg1a depleted most of
total Leg1 protein causing a more severe small liver phenotype
whereas knockdown of Leg1b moderately lowered total Leg1
protein causing a less severe small liver phenotype. Interestingly,
leg1a or leg1b mRNA injection alone partially rescued the small
liver phenotype of leg1-MO
ATG morphants to similar extents, and
was obviously less efficient than did the leg1a and leg1b mRNA co-
injection. Taken together, these results suggest that Leg1a and
Leg1b appear to play partially redundant roles in liver
development. However, the best way to clarify the role of Leg1a
and Leg1b in liver development is to get null mutations for each
Figure 9. N-terminal signal peptide is essential for Leg1 function. (A) Western analysis of Leg1 protein expression in WT, leg1-MO
ATG
morpahnt (MO-1), leg1-MO
ATG co-injected with leg1a (1a) (MO-1+1a lane) or leg1b (1b) (MO-1+1b lane) mRNA, with N-terminal signal peptide coding
sequence truncated leg1a (1a-T) (MO-1+1a-T lane) or leg1b (1b-T) (MO-1+1b-T lane) mRNA. (B) Statistical analysis of liver size based on WISH signal
intensity of fabp10a in each individual embryo from different treatment as stated. 20–23 embryos were used for statistical analysis in each case
except for MO-1 (15 embryos were used).
doi:10.1371/journal.pone.0022910.g009
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moment.
At the transcriptional level, in the adult fish, total leg1 transcripts
were detected mainly in the liver and were almost undetectable in
the head, tail, and trunk. At the translational level, in contrast,
similar levels of Leg1 protein were detected in the head, gut and
tail as that in the liver while Leg1 level is the highest in the serum.
Based on this observation we reckoned that Leg1 is likely to be a
novel liver-produced secretory protein. Protein domain analysis
identified a putative signal peptide in Leg1. We confirmed this
prediction by analyzing the translational product of injected leg1
tagged with HA-tag at either the N-terminal or C-terminal of
Leg1. Results showed that the HA-tag was cleaved off from Leg1
when it was tagged at the N-terminal of Leg1 whilst the HA-tag
was still fused with Leg1 when being tagged at the C-terminal of
Leg1. The nature of Leg1 to be a secreted protein might explain
why organogenesis of the exocrine pancreas and intestine are also
affected in the leg1-MO
ATG morphants if considering the
hypothesis that Leg1 is a novel secreted growth regulator. In fact,
our data showing that the N-terminal signal peptide is essential for
Leg1 function provides a strong evidence to support this
hypothesis.
I ns u m m a r y ,w eh a v eh e r ep r e s e n t e dd a t at od e m o n s t r a t e
that Leg1 is a novel liver-produced secretory protein that is
essential for digestive organ development in zebrafish.
However, many keys questions remain to be addressed in the
future. For example, what is the biochemical function of Leg1?
Is Leg1 a secreted enzyme, or a growth factor, or a carrier?
Will Leg1 form a complex with other protein(s) and how does
Leg1 exert its function on liver development? Future work to
address these questions will help to unravel the biological
functions of Leg1.
Supporting Information
Figure S1 Alignment of leg1a and leg1b full length cDNA
sequences. Translation start codon ATG and stop codon TGA
of both genes are boxed in red.
(JPG)
Figure S2 Alignment of leg1a and leg1b promoter
sequences. 3k bo fleg1a and leg1b genomic DNA sequences
upstream of their respective transcription start sites (letter in lower
case) were retrieved from Zv8/danRer6 assembled in UCSC
Genome Broswer (http://genome.ucsc.edu/cgi-bin/hgGateway),
respectively. For leg1a, the 3 kb is from the region of chr20:1,
478,061–1,481,060, and for leg1b, chr20:1,463,371–1,466,370.
Alignment was performed using Ebi Tool needle (http://www.
ebi.ac.uk/Tools/psa/emboss_needle/nucleotide.html). Parame-
ters were set as the following: Matrix: EDNAFULL, # Gap_pen-
alty: 50.0, Extend_penalty: 0.5. Alignment shows that there are
two conserved regions in leg1a and leg1b promoter (Region I, in
red; Region II, in purple). However, the rest of sequence,
especially the 600 bp proximal promoter sequence, is highly
divergent between these two genes.
(JPG)
Table S1 Statistical data for immunostaining of PH3.
(DOC)
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